Section Arrow
Quote
LAB.NASDAQ
- Standard BioTools
Quotes are at least 15-min delayed:2026/04/29 08:01 EDT
Pre Market
Last
 0.9224
0 (0.00%)
Bid
0.91
Ask
0.9224
High 0.94 
Low 0.9224 
Volume 933 
Regular Hours (Closed)
Last
 0.9224
+0.0239 (+2.66%)
Day High 
0.94 
Prev. Close
0.8985 
1-M High
1.0399 
Volume 
2.73M 
Bid
0.91
Ask
0.9224
Day Low
0.8856 
Open
0.894 
1-M Low
0.8701 
Market Cap 
350.48M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.93 
20-SMA 0.92 
50-SMA 0.99 
52-W High 1.72 
52-W Low 0.8701 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.20/-0.20
Enterprise Value
375.82M
Balance Sheet
Book Value Per Share
1.09
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
85.33M
Operating Revenue Per Share
0.27
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc.0.5553+0.0422+8.22%-- 
Pre Market 0.545 -0.0103 -1.85%
BSXBoston Scientific Corp58.45-1.5-2.50%30.9PE
Pre Market 58.2 -0.25 -0.43%
ABTAbbott Laboratories93.86+1.06+1.14%24.95PE
Pre Market 93.64 -0.22 -0.23%
MDTMedtronic plc81.9-1.02-1.23%23.16PE
Pre Market 81.68 -0.22 -0.27%
ZBHZimmer Biomet Holdings82.8-9.79-10.57%26.08PE
Pre Market 83 +0.2 +0.24%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.